

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301921293.html
https://www.prnewswire.com/news-releases/insmed-to-present-at-the-morgan-stanley-21st-annual-global-healthcare-conference-301918384.html
https://www.prnewswire.com/news-releases/insmed-to-host-second-quarter-2023-financial-results-conference-call-on-thursday-august-3-2023-301881491.html
https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301870467.html
https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301841689.html
https://www.prnewswire.com/news-releases/insmed-presents-range-of-new-study-findings-at-american-thoracic-society-2023-international-conference-301831230.html
https://www.prnewswire.com/news-releases/insmed-to-host-investor-and-analyst-event-on-may-8-2023-301805111.html
https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301790021.html
https://www.prnewswire.com/news-releases/insmed-completes-enrollment-of-adult-patients-in-phase-3-aspen-study-of-brensocatib-in-bronchiectasis-301786434.html
https://www.prnewswire.com/news-releases/insmed-to-present-new-clinical-pre-clinical-and-real-world-data-in-serious-and-rare-lung-diseases-at-the-american-thoracic-society-2023-international-conference-301781216.html